Back to Search
Start Over
Efficacy, Safety, Tolerability, and Pharmacokinetics of Human Immune Globulin Subcutaneous, 20% (IGSC 20%): Final Analysis of a Phase 2/3 Study in Patients with Primary Immunodeficiency Disease (PIDD) in North America.
- Source :
- Journal of Allergy & Clinical Immunology; Feb2016 Supplement, Vol. 137, pAB221-AB221, 1p
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 00916749
- Volume :
- 137
- Database :
- Supplemental Index
- Journal :
- Journal of Allergy & Clinical Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 112742689
- Full Text :
- https://doi.org/10.1016/j.jaci.2015.12.856